22 August,2022 07:18 PM IST | New Delhi | IANS
Image for representational purpose only. Photo Courtesy: istock
A new study has found that if blood tests are taken on the day of a traumatic brain injury (TBI), it can help predict which patients are likely to die or survive with severe disability thus letting clinicians make better decisions earlier about the possible treatment for the injury.
The findings, published in The Lancet Neurology, revealed that higher values of two protein biomarkers, GFAP and UCH-L1, are associated with death and severe injury.
"Early and accurate prediction of TBI outcomes will help clinicians gauge how severe a brain injury is and inform how best to counsel family members about care for their loved ones with brain injury and what to expect with regards to their recovery," said researcher Frederick Korley from the University of Michigan.
The US Food and Drug Administration (FDA) cleared the use of GFAP and UCH-L1 in 2018 to help clinicians decide whether to order CT scans for mild traumatic brain injury.
For the study, the team measured the proteins using two devices and analysed day-of-injury blood tests of nearly 1,700 patients with TBI.
ALSO READ
Mobile phone use can worsen heart disease in smokers, diabetics: Study
No link between sports concussions and cognitive problems: Study
India ranks 38th globally in suicide deaths: Report
Night owls may be at a higher risk of diabetes, finds study
Rising consumption of processed, packaged food in India to affect health outcome
Results were compared to evaluations made six months after injury using the Glasgow Outcome Scale-Extended, a system that grades the functional status of TBI patients.
Investigators found that compared to those with GFAP values in the bottom 20th percentile, those with GFAP values in the top 20th percentile had a 23 times higher risk of death during the subsequent six months.
Similarly, compared to those with UCH-L1 values in the bottom 20th percentile, those with UCH-L1 values in the top 20th percentile had a 63 times higher risk of death during the subsequent six months.
Also Read: Meditation apps see a decrease in the number of users as normal life resumes
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
